GlassScriptPhysician profile
Catherine Guidry
NPI 1992721252
$5,402.67
in general payments reported to CMS, 2019-2025
14 companies · $1,344 in 2025
The $1,344 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,595 · 2020: $145 · 2021: $116 · 2022: $1,539 · 2023: $170 · 2024: $493 · 2025: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819 · Education: $99.99 · Entertainment: $87.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,819.19 |
| Education | $99.99 |
| Entertainment | $87.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,460.63 | 2019-2025 | Clariti Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Biotissue Holdings INC. | $317.12 | 2019-2025 | |
| Glaukos Corporation | $288.80 | 2025 | Photrexa Viscous and Photrexa |
| Alcon Vision LLC | $287.54 | 2022-2025 | Tryptyr, Precision7, Precision 1 |
| Mallinckrodt Hospital Products INC. | $253.44 | 2024-2025 | Acthar |
| Dompe US, INC. | $216.07 | 2024-2025 | Oxervate |
| Allergan, INC. | $146.93 | 2019-2021 | |
| Oyster Point Pharma, INC. | $109.28 | 2022 | |
| Optos, INC. | $87.91 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $81.22 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $69.75 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $44.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $25.92 | 2023 | |
| Carl Zeiss Meditec, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Guidry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.